CBD Market: EU-wide Novel Food Applications and Current Status
Overview of CBD novel food application status in the EU.
Current Situation (as of Q4/2025)
- Over 50 CBD applications submitted to EFSA
- NO authorization granted so far
- Main problem: Insufficient toxicological data
- Sales bans in several EU countries (FR, IT partially)
Outlook
First authorizations not expected before 2026. Manufacturers should not market new CBD products without novel food status.
*Hinweis: Diese Zusammenfassung dient Informationszwecken. Die dargestellten Studienergebnisse sind keine zugelassenen Health Claims. Für detaillierte Informationen konsultieren Sie bitte die Originalquelle.
Related Posts
More articles from this category
Guide to the Safe Intake of Dietary Supplements
Comprehensive guide on supplement safety and dosage limits for 2026. Addresses risks of excessive intake and specific considerations for various vitamins and minerals.
New US Dietary Guidelines 2025-2030 Released
The Dietary Guidelines for Americans 2025-2030 were published on January 7, 2026, explicitly recognizing dietary supplements as a tool to close nutrient gaps.
Investigation Reveals Supplements with 12-Fold Overdose
Which? investigation finds dietary supplements with up to 12 times the safe maximum levels for vitamins and minerals on online platforms.